2 results
Approved WMOCompleted
To study the potential of baclofen as an anti-craving/relapse agent in GHB dependent patients.
Approved WMOCompleted
Primary objectivesThe primary objective of this trial is to evaluate the efficacy in terms of overall survival (OS) at 24 months of a chemotherapy-free dual HER2-inbibition with trastuzumab and pertuzumab (first-line) followed by T-DM1 (second-line…